Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial.
暂无分享,去创建一个
R K Ten Haken | M K Martel | J A Hayman | A S Lichter | M. Martel | R. T. Ten Haken | J. Hayman | A. Turrisi | D. Normolle | A. Lichter | M. Sullivan | D P Normolle | R. Todd | J F Littles | A T Turrisi | R F Todd | M A Sullivan | P W Possert | J. Littles | P. W. Possert | Robert F. Todd
[1] W. Curran,et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. , 1995, Journal of the National Cancer Institute.
[2] J. Purdy,et al. Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer. , 1995, International journal of radiation oncology, biology, physics.
[3] A B Wolbarst,et al. Optimization of radiation therapy, III: A method of assessing complication probabilities from dose-volume histograms. , 1987, International journal of radiation oncology, biology, physics.
[4] C. Shapiro,et al. The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy. , 1995, International journal of radiation oncology, biology, physics.
[5] W. Curran,et al. Analysis of the influence of elective nodal irradiation on postirradiation pulmonary function , 1990, Cancer.
[6] T. Landberg,et al. What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer? , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[7] G T Chen,et al. Optimization of radical radiotherapy with beam's eye view techniques for non-small cell lung cancer. , 1991, International journal of radiation oncology, biology, physics.
[8] T G Turkington,et al. Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects. , 1999, Lung cancer.
[9] W. Curran,et al. The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer. , 1990, International journal of radiation oncology, biology, physics.
[10] S. Kudoh,et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] G J Kutcher,et al. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. , 1995, International journal of radiation oncology, biology, physics.
[12] G J Kutcher,et al. Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation. , 1999, International journal of radiation oncology, biology, physics.
[13] J. Herndon,et al. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. , 1996, Journal of the National Cancer Institute.
[14] K L Lam,et al. Measurement of patient setup errors using port films and a computer-aided graphical alignment tool. , 1996, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.
[15] H. Kubo,et al. Respiration gated radiotherapy treatment: a technical study. , 1996, Physics in medicine and biology.
[16] R. Mohan,et al. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. , 1991, International journal of radiation oncology, biology, physics.
[17] H. Bartelink,et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. , 1992, The New England journal of medicine.
[18] J. Crowley,et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] K Schnabel,et al. 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. , 1999, International journal of radiation oncology, biology, physics.
[20] J. Wong,et al. The use of active breathing control (ABC) to reduce margin for breathing motion. , 1999, International journal of radiation oncology, biology, physics.
[21] W. Stanford,et al. Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography. , 1990, International journal of radiation oncology, biology, physics.
[22] R. Arriagada,et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. , 1991, Journal of the National Cancer Institute.
[23] N. Gross. Pulmonary effects of radiation therapy. , 1977, Annals of internal medicine.
[24] M. Martel,et al. 186 Incidental dose to clinically negative nodes from conformal treatment fields for nonsmall cell lung cancer , 1999 .
[25] H S Glazer,et al. Three-dimensional radiation treatment planning study for patients with carcinoma of the lung. , 1994, International journal of radiation oncology, biology, physics.
[26] C. Perez,et al. Impact of tumor control on survival in carcinoma of the lung treated with irradiation. , 1986, International journal of radiation oncology, biology, physics.
[27] M. Anscher,et al. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. , 1998, International journal of radiation oncology, biology, physics.
[28] R K Ten Haken,et al. Use of Veff and iso-NTCP in the implementation of dose escalation protocols. , 1993, International journal of radiation oncology, biology, physics.
[29] M. Goitein,et al. Fitting of normal tissue tolerance data to an analytic function. , 1991, International journal of radiation oncology, biology, physics.
[30] A Harvey,et al. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[31] M. Kris,et al. Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[32] S U Berlangieri,et al. The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. , 1998, Lung cancer.
[33] J. Hendry,et al. The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-control data. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[34] E. Noordijk,et al. Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. , 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[35] M. Goitein,et al. Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.
[36] P. Blitzer,et al. Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies. , 1992, International journal of radiation oncology, biology, physics.
[37] M. Martel,et al. Dose escalation for non-small cell lung cancer using conformal radiation therapy. , 1997, International journal of radiation oncology, biology, physics.
[38] J. Lyman. Complication Probability as Assessed from Dose-Volume Histograms , 1985 .
[39] R K Ten Haken,et al. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. , 1994, International journal of radiation oncology, biology, physics.
[40] G J Kutcher,et al. Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.
[41] S. Anthony,et al. Chemotherapy plus Radiotherapy Compared with Radiotherapy Alone in the Treatment of Locally Advanced, Unresectable, Non-Small-Cell Lung Cancer , 1996, Annals of Internal Medicine.